Molnupiravir reasonable cost online

Jul 2, 2022 · Thus, the expected monetary loss per patient by a decision maker who chooses best supportive care as an optimal strategy is $21,464 (at $100,000 per QALY); however, there is no loss to a decision maker for molnupiravir. The huge reduction in the risk of mortality observed in our meta-analysis is highly encouraging

2024-03-28
    Will levaquin treat strep throat
  1. Middle East
  2. An
  3. 31 Cost of production – treatment regimen $12
  4. WHO Team
  5. NEJM Evid 2022;1(2 General Information
  6. The mechanisms of action of molnupiravir against SARS-CoV-2